Huhn, G. D., Tebas, P., Gallant, J., Wilkin, T., Cheng, A., Yan, M., . . . McCallister, S. (2017). A Randomized, Open-Label Trial to Evaluate Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Plus Darunavir in Treatment-Experienced HIV-1-Infected Adults. J Acquir Immune Defic Syndr.
Citação norma ChicagoHuhn, Gregory D., et al. "A Randomized, Open-Label Trial to Evaluate Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Plus Darunavir in Treatment-Experienced HIV-1-Infected Adults." J Acquir Immune Defic Syndr 2017.
Citação norma MLAHuhn, Gregory D., et al. "A Randomized, Open-Label Trial to Evaluate Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Plus Darunavir in Treatment-Experienced HIV-1-Infected Adults." J Acquir Immune Defic Syndr 2017.